182PEfficacy and tolerability of neratinib in advanced HER-2 positive breast cancer: A single institution experience. (13th May 2019) - Shepherd, S T C; Lee, K; Mohammed, K; Patel, K; Allen, M; Johnston, S R D; Parton, M; Ring, A; Turner, N; Okines, A F C